The chemistry and pharmacology of Ligularia przewalskii: A review. 2018

Shi-Jun Liu, and Zhi-Shu Tang, and Zhi-Xin Liao, and Chun-Li Cui, and Hong-Bo Liu, and Yan-Ni Liang, and Yu Zhang, and Hong-Bo Xu, and Dong-Bo Zhang, and Ya-Ting Zheng, and Huan-Xian Shi, and Shi-Ying Li
Shaanxi University of Chinese Medicine/Shaanxi Collaborative Innovation Center of Chinese Medicinal Resource Industrialization, Xianyang 712083, China; Shaanxi Province Key Laboratory of New Drugs and Chinese Medicine Foundation Research, Xianyang 712083, China; Shaanxi Rheumatism and Tumor Center of TCM Engineering Technology Research, Xianyang 712083, China. Electronic address: l181618@126.com.

BACKGROUND Ligularia przewalskii (Maxim.) Diels (LP) (called zhangyetuowu in Chinese), is generally found in moist forest areas in the western regions of China. The root, leaves and flower of LP are utilized as a common traditional medicine in China. It has been utilized conventionally in herbal remedies for the remedy of haemoptysis, asthma, pulmonary phthisis, jaundice hepatitis, food poisoning, bronchitis, cough, fever, wound healing, measles, carbuncle, swelling and phlegm diseases. OBJECTIVE The review aims to provide a systematic summary of LP and to reveal the correlation between the traditional uses and pharmacological activities in order to provide updated, comprehensive and categorized information and identify the therapeutic potential for its use as a new medicine. METHODS The relevant data were searched by using the keywords "Ligularia przewalskii" "phytochemistry", "pharmacology", "Traditional uses", and "Toxicity" in "Scopus", "Scifinder", "Springer", "Pubmed", "Wiley", "Web of Science", "China Knowledge Resource Integrated databases (CNKI)", "Ph.D." and "M.Sc. dissertations", and a hand-search was done to acquire peer-reviewed articles and reports about LP. The plant taxonomy was validated by the databases "The Plant List", "Flora Reipublicae Popularis Sinicae", "A Collection of Qinghai Economic Plants", "Inner Mongolia plant medicine Chi", Zhonghua-bencao and the Standard of Chinese herbal medicine in Gansu. RESULTS Based on the traditional uses, the chemical nature and biological effects of LP have been the focus of research. In modern research, approximately seventy-six secondary metabolites, including thirty-eight terpenoids, nine benzofuran derivatives, seven flavonoids, ten sterols and others, were isolated from this plant. They exhibit anti-inflammatory, antioxidative, anti-bacterial and anti-tumour effects, and so on. Currently, there is no report on the toxicity of LP, but hepatotoxic pyrrolizidine alkaloids (HPA) were first detected with LC/MSn in LP, and they have potential hepatotoxicity. CONCLUSIONS The lung-moistening, cough-relieving and phlegm-resolving actions of the root of LP are attributed to the anti-inflammatory properties of flavonoids and terpenoids. The heat-clearing, dampness-removing and gallbladder-normalizing (to cure jaundice) actions of the flowers of LP are based on the anti-inflammatory, antioxidant and hepatoprotective activity properties of terpenoids, flavonoids and sterols. The Traditional Chinese Medicine (TCM) characteristics of LP (bitter flavour) corroborate its potent anti-inflammatory effects. In addition, the remarkable anti-inflammatory and antioxidant capacities of LP contribute to its anti-tumour and antitussive activities. Many conventional uses of LP have now been validated by modernized pharmacological research. For future research, further phytochemical and biological studies need to be conducted on LP, In particular, the safety, mechanism of action and efficacy of LP could be of future research interest before beginning clinical trials. More in vivo experiments and clinical studies are encouraged to further clarify the relation between traditional uses and modern applications. Regarding the roots, leaves and flowers of LP, their chemical compositions and clinical effects should be compared. The information on LP will be helpful in providing and identifying its therapeutic potential and economic value for its use as a new medicine in the future.

UI MeSH Term Description Entries
D008516 Medicine, Chinese Traditional A system of traditional medicine which is based on the beliefs and practices of the Chinese culture. Chinese Medicine, Traditional,Chung I Hsueh,Traditional Medicine, Chinese,Zhong Yi Xue,Chinese Traditional Medicine,Traditional Chinese Medicine,Traditional Tongue Assessment,Traditional Tongue Diagnosis,Hsueh, Chung I,Tongue Assessment, Traditional,Tongue Diagnoses, Traditional,Tongue Diagnosis, Traditional,Traditional Tongue Assessments,Traditional Tongue Diagnoses
D008517 Phytotherapy Use of plants or herbs to treat diseases or to alleviate pain. Herb Therapy,Herbal Therapy
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D012120 Respiration Disorders Diseases of the respiratory system in general or unspecified or for a specific respiratory disease not available. Disorder, Respiration,Disorders, Respiration,Respiration Disorder
D004365 Drugs, Chinese Herbal Chinese herbal or plant extracts which are used as drugs to treat diseases or promote general well-being. The concept does not include synthesized compounds manufactured in China. Chinese Herbal Drugs,Plant Extracts, Chinese,Chinese Drugs, Plant,Chinese Plant Extracts,Extracts, Chinese Plant,Herbal Drugs, Chinese
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000972 Antineoplastic Agents, Phytogenic Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. Antineoplastics, Botanical,Antineoplastics, Phytogenic,Agents, Phytogenic Antineoplastic,Botanical Antineoplastics,Phytogenic Antineoplastic Agents,Phytogenic Antineoplastics
D000975 Antioxidants Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. Anti-Oxidant,Antioxidant,Antioxidant Activity,Endogenous Antioxidant,Endogenous Antioxidants,Anti-Oxidant Effect,Anti-Oxidant Effects,Anti-Oxidants,Antioxidant Effect,Antioxidant Effects,Activity, Antioxidant,Anti Oxidant,Anti Oxidant Effect,Anti Oxidant Effects,Anti Oxidants,Antioxidant, Endogenous,Antioxidants, Endogenous
D019659 Asteraceae A large plant family of the order Asterales, subclass Asteridae, class Magnoliopsida. The family is also known as Compositae. Flower petals are joined near the base and stamens alternate with the corolla lobes. The common name of "daisy" refers to several genera of this family including Aster; CHRYSANTHEMUM; RUDBECKIA; TANACETUM. Aspilia,Carpesium,Clibadium,Compositae,Doronicum,Emilia Plant,Heterotheca,Iostephane,Leopard's Bane, False,Lychnophora,Phagnalon,Sphaeranthus,Trixis,Viguiera,Enhydra fluctuans,Ixeris,Pseudognaphalium,Silphium,Aspilias,Bane, False Leopard's,Banes, False Leopard's,Carpesiums,Clibadiums,Doronicums,Emilia Plants,Enhydra fluctuan,False Leopard's Bane,False Leopard's Banes,Heterothecas,Iostephanes,Ixeri,Leopard Bane, False,Leopard's Banes, False,Leopards Bane, False,Lychnophoras,Phagnalons,Plant, Emilia,Plants, Emilia,Pseudognaphaliums,Silphiums,Trixi,Viguieras,fluctuan, Enhydra

Related Publications

Shi-Jun Liu, and Zhi-Shu Tang, and Zhi-Xin Liao, and Chun-Li Cui, and Hong-Bo Liu, and Yan-Ni Liang, and Yu Zhang, and Hong-Bo Xu, and Dong-Bo Zhang, and Ya-Ting Zheng, and Huan-Xian Shi, and Shi-Ying Li
September 2013, Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials,
Shi-Jun Liu, and Zhi-Shu Tang, and Zhi-Xin Liao, and Chun-Li Cui, and Hong-Bo Liu, and Yan-Ni Liang, and Yu Zhang, and Hong-Bo Xu, and Dong-Bo Zhang, and Ya-Ting Zheng, and Huan-Xian Shi, and Shi-Ying Li
June 2006, Die Pharmazie,
Shi-Jun Liu, and Zhi-Shu Tang, and Zhi-Xin Liao, and Chun-Li Cui, and Hong-Bo Liu, and Yan-Ni Liang, and Yu Zhang, and Hong-Bo Xu, and Dong-Bo Zhang, and Ya-Ting Zheng, and Huan-Xian Shi, and Shi-Ying Li
April 2024, The Journal of pharmacy and pharmacology,
Shi-Jun Liu, and Zhi-Shu Tang, and Zhi-Xin Liao, and Chun-Li Cui, and Hong-Bo Liu, and Yan-Ni Liang, and Yu Zhang, and Hong-Bo Xu, and Dong-Bo Zhang, and Ya-Ting Zheng, and Huan-Xian Shi, and Shi-Ying Li
May 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Shi-Jun Liu, and Zhi-Shu Tang, and Zhi-Xin Liao, and Chun-Li Cui, and Hong-Bo Liu, and Yan-Ni Liang, and Yu Zhang, and Hong-Bo Xu, and Dong-Bo Zhang, and Ya-Ting Zheng, and Huan-Xian Shi, and Shi-Ying Li
May 2021, Molecules (Basel, Switzerland),
Shi-Jun Liu, and Zhi-Shu Tang, and Zhi-Xin Liao, and Chun-Li Cui, and Hong-Bo Liu, and Yan-Ni Liang, and Yu Zhang, and Hong-Bo Xu, and Dong-Bo Zhang, and Ya-Ting Zheng, and Huan-Xian Shi, and Shi-Ying Li
June 2013, Chinese journal of integrative medicine,
Shi-Jun Liu, and Zhi-Shu Tang, and Zhi-Xin Liao, and Chun-Li Cui, and Hong-Bo Liu, and Yan-Ni Liang, and Yu Zhang, and Hong-Bo Xu, and Dong-Bo Zhang, and Ya-Ting Zheng, and Huan-Xian Shi, and Shi-Ying Li
May 2009, Phytochemistry,
Shi-Jun Liu, and Zhi-Shu Tang, and Zhi-Xin Liao, and Chun-Li Cui, and Hong-Bo Liu, and Yan-Ni Liang, and Yu Zhang, and Hong-Bo Xu, and Dong-Bo Zhang, and Ya-Ting Zheng, and Huan-Xian Shi, and Shi-Ying Li
February 2014, Chinese journal of natural medicines,
Shi-Jun Liu, and Zhi-Shu Tang, and Zhi-Xin Liao, and Chun-Li Cui, and Hong-Bo Liu, and Yan-Ni Liang, and Yu Zhang, and Hong-Bo Xu, and Dong-Bo Zhang, and Ya-Ting Zheng, and Huan-Xian Shi, and Shi-Ying Li
January 2014, Biomedical reports,
Shi-Jun Liu, and Zhi-Shu Tang, and Zhi-Xin Liao, and Chun-Li Cui, and Hong-Bo Liu, and Yan-Ni Liang, and Yu Zhang, and Hong-Bo Xu, and Dong-Bo Zhang, and Ya-Ting Zheng, and Huan-Xian Shi, and Shi-Ying Li
August 2001, Journal of ethnopharmacology,
Copied contents to your clipboard!